NCT00704366 2011-05-16AZD0530 Study 21 - Phase I Study in Patients With Solid TumoursAstraZenecaPhase 1 Completed18 enrolled
NCT00475956 2010-04-15Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursAstraZenecaPhase 1 Completed40 enrolled